Due to the global expansion of pharmaceutical markets, counterfeit drugs are a growing problem, not only in developing nations but even in ‘premium markets’ such as the US and Europe. Counterfeit medicines are threatening public health as well as the reputation of the legitimate pharmaceutical industry.
In this issue we investigate the extent of the problem and how the industry and health organisations are responding. We ask market analysts about the trends in counterfeits and speak to experts about security measures that can be taken at the packaging and labelling stages, as well as looking at tracking and end-to-end verification solutions that can help to prevent counterfeit products from infiltrating the pharmaceutical supply chain.
Go deeper with GlobalData
To read your free copy, click here.
Combating the Counterfeit Culture
The global counterfeit medicines market is threatening public health and the reputation of the legitimate pharmaceutical industry. We investigate the extent of the problem and find out how the industry and health organisations are responding.
Read the full article
What the Doctor Didn’t Order
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataAs the number of counterfeit drugs on the market continues to rise, we ask Global Insight analysts Shuang Lewis and Denise Claux for the lowdown on the potentially deadly medicines.
Read the full article
Operation Drugs Bust
How can companies ensure the integrity of their products in the face of the counterfeit threat? Nic Paton speaks to Katherine Eban, author of a book on the subject, about the black market for medicines.
Read the full article
Track and Verify
The real danger of counterfeit medicine is not the profit loss for the industry, but the threat to patient health. We speak to pharmaceutical labelling and identification specialist Ray Collia-Suzuki about the technology being used to combat counterfeit drugs and medical equipment.
Read the full article
Border Control
Governments and regulatory bodies are constantly seeking new ways to counter the growing risk of pharmaceutical counterfeit products infiltrating the supply chain. We explain how EFPIA’s new coding initiative, piloted in Sweden, provides a model for an end-to-end verification solution that will offer robust protection.
Read the full article
Redirecting the Traffic
With the trade in black market medicines nearing epidemic proportions, can recently introduced EU pharmaceuticals packaging legislation drive counterfeiting off the world’s highways?
Read the full article
Next Issue
Manufacturing ingredients for pharmaceutical products is a burgeoning industry. Next month we look at new methods currently being used to manufacture high grade materials synthetically and even bio-technologically.
We also find out how manufacturing companies can ensure they meet regulations and prove they are satisfying GMP requirements, and explore the issues surrounding the use of water in the pharmaceutical manufacturing process.
Security of supply, cost and ease of doing business have been the major draw cards for outsourcing manufacturing, but as companies emerge from recession, quick turnaround is becoming more important. We speak to experts about the trends in contract manufacturing.
Digital Magazine FAQ
The digital magazine is viewable on any computer with Flash Player installed. It is also viewable on mobile devices, iPhones and iPads, although some features and videos may be disabled.
To read the latest issue, click here.
